Abstract
The simple sphingolipids ceramide, sphingosine, ceramide 1-phosphate and sphingosine 1-phosphate, and their metabolizing enzymes are implicated in the regulation of vital cellular functions, including angiogenesis, cell differentiation, migration, and cell growth and death. These sphingolipids are also involved in the establishment and progression of many illnesses including cardiovascular diseases such as atherosclerosis, or neurodegenerative diseases such as Parkinson's or Alzheimer's diseases, chronic inflammation, and cancer. Therefore, the development of inhibitors of the enzymes that are responsible for the synthesis and degradation of these metabolites may be essential tools for studying normal cell metabolism as well as for establishing new therapeutic strategies for treatment of disease.
Keywords: Apoptosis, cell proliferation, cell migration, inflammation, ceramides, ceramide-1-phosphate, sphingolipids, sphingosine 1-phosphate, atherosclerosis, ageing
Current Enzyme Inhibition
Title:Inhibition of Ceramide Metabolism Key Enzymes and its Implication in Cell Physiology and Pathology
Volume: 7 Issue: 4
Author(s): Antonio Gomez-Munoz, Alberto Ouro, Lide Arana, Io-Guane Rivera, Marta Ordonez, Patricia Gangoiti, Miguel Trueba
Affiliation:
Keywords: Apoptosis, cell proliferation, cell migration, inflammation, ceramides, ceramide-1-phosphate, sphingolipids, sphingosine 1-phosphate, atherosclerosis, ageing
Abstract:
The simple sphingolipids ceramide, sphingosine, ceramide 1-phosphate and sphingosine 1-phosphate, and their metabolizing enzymes are implicated in the regulation of vital cellular functions, including angiogenesis, cell differentiation, migration, and cell growth and death. These sphingolipids are also involved in the establishment and progression of many illnesses including cardiovascular diseases such as atherosclerosis, or neurodegenerative diseases such as Parkinson's or Alzheimer's diseases, chronic inflammation, and cancer. Therefore, the development of inhibitors of the enzymes that are responsible for the synthesis and degradation of these metabolites may be essential tools for studying normal cell metabolism as well as for establishing new therapeutic strategies for treatment of disease.
Export Options
About this article
Cite this article as:
Antonio Gomez-Munoz, Alberto Ouro, Lide Arana, Io-Guane Rivera, Marta Ordonez, Patricia Gangoiti, Miguel Trueba , Inhibition of Ceramide Metabolism Key Enzymes and its Implication in Cell Physiology and Pathology, Current Enzyme Inhibition 2011; 7 (4) . https://dx.doi.org/10.2174/157340811799860551
DOI https://dx.doi.org/10.2174/157340811799860551 |
Print ISSN 1573-4080 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6662 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Approaches to Improve the Antitumor Efficacy of Temozolomide
Current Medicinal Chemistry A Dual Mechanism Linking NGF/proNGF Imbalance and Early Inflammation to Alzheimer's Disease Neurodegeneration in the AD11 Anti-NGF Mouse Model
CNS & Neurological Disorders - Drug Targets Psychomotor Seizure Screening and in vitro Neuroprotection Assay of Hydrazones Derived from 2-Acetyl Thiophene
Central Nervous System Agents in Medicinal Chemistry Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application
Current Drug Metabolism Neuroprotective Effects of Agomelatine and Vinpocetine Against Chronic Cerebral Hypoperfusion Induced Vascular Dementia
Current Neurovascular Research Cognitive Impairment and Diabetes
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery The Urocortins: Mechanisms of Cardioprotection and Therapeutic Potential
Mini-Reviews in Medicinal Chemistry The Synergic Role of Environmental Contaminants in the Immunological Effects of Viral Diseases, Such as COVID-19
Coronaviruses Contribution of Mast Cells to Cerebral Aneurysm Formation
Current Neurovascular Research Gender Bias in Acute Coronary Syndromes
Current Vascular Pharmacology Adolescent Risk Pathways Toward Schizophrenia: Sustained Attention and the Brain
Current Topics in Medicinal Chemistry Inhibitory Effect of Ebselen on Cerebral Acetylcholinesterase Activity In Vitro: Kinetics and Reversibility of Inhibition
Current Pharmaceutical Design Unraveling Effector Functions of B Cells During Infection: The Hidden World Beyond Antibody Production
Infectious Disorders - Drug Targets Erythropoietin Gene Polymorphism rs551238 is Associated with a Reduced Susceptibility to Brain Injury in Preterm Infants
Current Neurovascular Research Conference Report: 182nd AAAS Annual Meeting, Washington DC, February 11-15, 2016
CNS & Neurological Disorders - Drug Targets Clinical Significance of the Blood Pressure Changes from Day to Night
Current Hypertension Reviews Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) The Putative Use of Lithium in Alzheimer’s Disease
Current Alzheimer Research Overview of Genomic Insights into Chicken Growth Traits Based on Genome- Wide Association Study and microRNA Regulation
Current Genomics Conference Report: (13th International Congress on Amino Acids, Peptides and Proteins (ICAPP); Neurobiology Symposium, October 5-7, 2013; Galveston TX, USA.)
CNS & Neurological Disorders - Drug Targets